The Oncology Institute, Inc. (TOI) Misses Q2 EPS by 6c

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q2 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $119.8 million versus the consensus estimate of $112.56 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Huang and Altman to attend Trump-Xi state dinner - ABC
• Germany’s Merz says era of "unconditional" friendship with U.S. is over
• FAA officials are preparing to launch an AI-powered air-traffic tool in one of the nation’s busiest corridors as soon as Monday - WSJ